Acropolis Investment Management, LLC Pfizer Inc Transaction History

Acropolis Investment Management, LLC

$2.05 Billion
Q3 2025

A detailed history of Acropolis Investment Management, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Acropolis Investment Management, LLC holds 17,239 shares of PFE stock, worth $424,941. This represents 0.02% of its overall portfolio holdings.

Number of Shares

17,239

Previous 13,785 25.06%

Holding current value

$424,941

Previous $334,000 31.44%

% of portfolio

0.02%

Previous 0.02%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 07, 2025	BUY	$23.29 - $25.88 $80,443 - $89,389	3,454 Added 25.06%	17,239 $439,000
Q2 2025 Jul 14, 2025	SELL	$21.59 - $24.84 $40,653 - $46,773	-1,883 Reduced 12.02%	13,785 $334,000
Q1 2025 Apr 17, 2025	BUY	$25.01 - $27.13 $41,266 - $44,764	1,650 Added 11.77%	15,668 $397,000
Q4 2024 Jan 14, 2025	BUY	$24.8 - $30.19 $7,787 - $9,479	314 Added 2.29%	14,018 $371,000
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $9,639 - $10,923	-348 Reduced 2.48%	13,704 $396,000
Q2 2024 Jul 16, 2024	BUY	$25.26 - $29.6 $1,641 - $1,924	65 Added 0.46%	14,052 $393,000
Q1 2024 Apr 17, 2024	BUY	$25.89 - $29.73 $7,585 - $8,710	293 Added 2.14%	13,987 $388,000
Q4 2023 Jan 16, 2024	SELL	$26.13 - $33.94 $31,016 - $40,286	-1,187 Reduced 7.98%	13,694 $394,000
Q3 2023 Oct 11, 2023	SELL	$32.09 - $37.51 $75,828 - $88,636	-2,363 Reduced 13.7%	14,881 $493,000
Q2 2023 Jul 13, 2023	SELL	$36.12 - $41.79 $3,864 - $4,471	-107 Reduced 0.62%	17,244 $632,000
Q1 2023 Apr 11, 2023	BUY	$39.39 - $51.28 $49,552 - $64,510	1,258 Added 7.82%	17,351 $707,000
Q4 2022 Jan 11, 2023	BUY	$41.75 - $54.5 $78,030 - $101,860	1,869 Added 13.14%	16,093 $0
Q3 2022 Oct 12, 2022	SELL	$43.76 - $53.42 $3,719 - $4,540	-85 Reduced 0.59%	14,224 $622,000
Q2 2022 Jul 15, 2022	BUY	$46.53 - $55.17 $26,056 - $30,895	560 Added 4.07%	14,309 $750,000
Q1 2022 Apr 08, 2022	BUY	$45.75 - $56.69 $33,168 - $41,100	725 Added 5.57%	13,749 $712,000
Q4 2021 Jan 14, 2022	BUY	$41.32 - $61.25 $11,941 - $17,701	289 Added 2.27%	13,024 $769,000
Q3 2021 Oct 12, 2021	BUY	$39.25 - $50.42 $7,104 - $9,126	181 Added 1.44%	12,735 $511,000
Q2 2021 Jul 16, 2021	BUY	$35.91 - $40.68 $71 - $81	2 Added 0.02%	12,554 $492,000
Q1 2021 Apr 12, 2021	BUY	$33.49 - $37.77 $13,429 - $15,145	401 Added 3.3%	12,552 $455,000
Q4 2020 Jan 13, 2021	BUY	$33.47 - $42.56 $24,633 - $31,324	736 Added 6.45%	12,151 $447,000
Q3 2020 Oct 09, 2020	BUY	$31.75 - $37.25 $82,740 - $97,073	2,606 Added 29.58%	11,415 $419,000
Q2 2020 Jul 15, 2020	BUY	$30.12 - $36.54 $60 - $73	2 Added 0.02%	8,809 $288,000
Q1 2020 Apr 10, 2020	BUY	$27.03 - $38.62 $21,056 - $30,084	779 Added 9.7%	8,807 $287,000
Q4 2019 Jan 14, 2020	BUY	$32.92 - $37.36 $2,008 - $2,278	61 Added 0.77%	8,028 $308,000
Q3 2019 Oct 15, 2019	SELL	$32.49 - $42.13 $5,945 - $7,709	-183 Reduced 2.25%	7,967 $286,000
Q2 2019 Jul 11, 2019	SELL	$36.98 - $41.52 $73,923 - $82,998	-1,999 Reduced 19.7%	8,150 $353,000
Q4 2018 Jan 10, 2019	BUY	$38.47 - $43.86 $13,464 - $15,351	350 Added 3.57%	10,149 $443,000
Q3 2018 Oct 03, 2018	BUY	$34.47 - $41.81 $48,602 - $58,952	1,410 Added 16.81%	9,799 $432,000
Q2 2018 Jul 12, 2018	BUY	$32.98 - $35.16 $2,176 - $2,320	66 Added 0.79%	8,389 $304,000
Q1 2018 Apr 04, 2018	SELL	$31.91 - $37.02 $22,624 - $26,247	-709 Reduced 7.85%	8,323 $295,000
Q4 2017 Jan 11, 2018	BUY	$33.26 - $35.29 $80,289 - $85,190	2,414 Added 36.48%	9,032 $327,000
Q3 2017 Oct 17, 2017	BUY	$31.0 - $34.15 $140,554 - $154,836	4,534 Added 217.56%	6,618 $236,000
Q3 2017 Oct 12, 2017	BUY	$31.0 - $34.15 $64,604 - $71,168	2,084	2,084 $236,000

Others Institutions Holding PFE

# of Institutions

3,314

Shares Held

3.65B

Call Options Held

96.6M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $138B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acropolis Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acropolis Investment Management, LLC with notifications on news.

Account

Acropolis Investment Management, LLC Pfizer Inc Transaction History